Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Congenital Anomalies|August 26, 2004
Thalidomide for the treatment of multiple myelomaYutaka Hattori, Toyotaka Iguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Soft tissue amyloidoma]Toyotaka Iguchi, Masahiro Kizaki, Asako Kurauchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 3, 2003
[Chronic myelogenous leukemia in a lymphoblastic crisis complicated with deep venous thrombosis successfully treated by thromboembolectomy]Toyotaka Iguchi, Kenji Yokoyama, Tamihiro Kamata, et al.
International Journal of Hematology|November 22, 2005
Multilineage involvement of light microscopic myeloperoxidase-negative acute leukemiaToyotaka Iguchi, Yuko Yamada, Norihiro Awaya, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Pulmonary tuberculosis and adenovirus-hemorrhagic cystitis after autologous peripheral blood stem cell transplantation for follicular lymphoma]Toyotaka Iguchi, Kenji Yokoyama, Masanori Mitsuishi, et al.
International Journal of Molecular Medicine|January 22, 2008
Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomideToyotaka Iguchi, Tomomi Yachide-Noguchi, Yuichi Hashimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma]Toyotaka Iguchi, Mariyo Sakoda, Chien-kang Chen, et al.
International Journal of Oncology|July 6, 2007
Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cellsToyotaka Iguchi, Yoshitaka Miyakawa, Kaori Saito, et al.
Pageof 3